Back

Genetic variations in PEAR1 are associated with progression of coronary artery disease

30 August 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Pathophysiology of coronary artery disease: new insights Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Wenchang Nie

Peking University Peoples' Hospital, Beijing (China)

7 More presentations in this session

Presentation thumbnail
Role of inflammation and cholesterol efflux in myocardial infarction patients without standard modifiable risk factors
Professor J. Silvain (Paris, FR) Doctor P. Guedeney (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Gene-gene and gene-environment interaction in coronary artery disease risk
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Reduced inflammation assessed by pericoronary adipose tissue is associated with coronary plaque calcification
Doctor K. Overgaard (Svendborg, DK)
Abstract Slides Video
Presentation thumbnail
Antibodies against phosphorylcholine in prediction of cardiovascular disease among women: a population-based prospective cohort study.
Professor J. Frostegard (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Association of the lipoprotein(a) gene (LPA) p.Ile4399Met variant with lipoprotein(a) level and cardiovascular events in patients following coronary artery bypass grafting under 65 years of age
Miss A. Golab (Szczecin, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of coronary artery disease: new insights

The Event

Event poster

ESC Congress 2024

30 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Progress in understanding the genetic underpinning of coronary artery disease: from genotype to phenotype
thumbnail
Congress Presentation
Platelet-endothelial aggregation receptor 1 inhibits reendothelialization of injured arteries
thumbnail
Congress Presentation
Association of genetic mutations and polymorphisms with coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources